Compounds > ns 1608
Page last updated: 2024-09-04

ns 1608 and pf 04217903

ns 1608 has been researched along with pf 04217903 in 1 studies

Compound Research Comparison

Studies
(ns 1608)		Trials
(ns 1608)		Recent Studies (post-2010)
(ns 1608)		Studies
(pf 04217903)		Trials
(pf 04217903)		Recent Studies (post-2010) (pf 04217903)
90123022

Protein Interaction Comparison

ProteinTaxonomyns 1608 (IC50)pf 04217903 (IC50)
cGMP-specific 3',5'-cyclic phosphodiesteraseCanis lupus familiaris (dog)8.06
Hepatocyte growth factor receptorHomo sapiens (human)0.0136
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)3.33
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)1.3
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AHomo sapiens (human)2.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1

Other Studies

1 other study(ies) available for ns 1608 and pf 04217903

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011